Alta Biomed

Alta Biomed

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Alta Biomed, founded in 2018 and based in San Diego, is a developer and manufacturer of proprietary surface coating technologies for medical devices. Its core asset is the Polyzene-F (PzF) nanocoating, a highly biocompatible polymer engineered to reduce thrombosis and inflammation. The company operates primarily as a B2B service provider, offering coating services, hemocompatibility testing, and co-development partnerships to medical device OEMs, leveraging a technology with a prior commercial exit to Boston Scientific.

CardiologyOncologyRadiology

Technology Platform

Proprietary Polyzene-F (PzF) nanocoating, an inorganic perfluorinated polymer designed to be highly biocompatible, antithrombotic, anti-inflammatory, and pro-healing for medical device surfaces.

Opportunities

The growing global medical device market, especially in cardiovascular and neurovascular implants, drives demand for advanced biocompatible coatings that improve safety and reduce drug dependence.
Alta Biomed's partnership model allows it to leverage the R&D of multiple device OEMs, creating a scalable path to market for its proven PzF technology.

Risk Factors

Success is highly dependent on securing and retaining partnerships with device manufacturers in a competitive coatings landscape.
Regulatory approval for each new device application rests with partners, creating indirect execution risk, and any long-term safety concerns with the coating could damage the platform's reputation.

Competitive Landscape

Alta Biomed competes with other medical device coating companies offering passive polymer coatings, hydrophilic coatings, and drug-eluting technologies. Key differentiators are PzF's specific anti-thrombotic/anti-inflammatory claims and its historical validation in commercially acquired products. Competition also comes from in-house coating expertise at large device OEMs.